03/25/2026 | Press release | Distributed by Public on 03/25/2026 09:10
The 2025 Annual Report of the Advisory Group on Biomarkers of Effect (AGoB) details the group's establishment, objectives, and activities in supporting EFSA's development of guidance on biomarkers of effect (BoEs) in regulatory risk assessment. The report outlines AGoB's collaborative efforts, meeting summaries, scientific advice and plans for future work.